Carol A. Carter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Carol A. Carter has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Lorna S. Ehrlich
Department of Molecular Genetics & Microbiology, Stony Brook University, Life Sciences Building Room 248, Stony Brook, NY 11794-5222, USA
8 shared publicationsFadila Bouamr
Laboratory of Molecular Biophysics and Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-8013, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1576, and Department of Molecular Genetics and Microbiology, Life Sciences Building, State University of New York, Stony Brook, New York 11794
4 shared publicationsGisselle N. Medina
Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794-5222, USA
4 shared publicationsJonathan Leis
Department of Microbiology & Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611
3 shared publicationsKang Chen
Laboratory of Molecular Biophysics, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA
3 shared publications- Claudia C. Cornilescu
University of Wisconsin-Madison, Department of Biochemistry (Madison, WI)
2 shared publications
Latest Publications
- Open Access
- 1 January 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (3) , 1511-1520
The Maturational Refolding of the β-Hairpin Motif of Equine Infectious Anemia Virus Capsid Protein Extends Its Helix α1 at Capsid Assembly Locus
- 1 January 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (3) , 1511-1520
Open AccessThe Maturational Refolding of the β-Hairpin Motif of Equine Infectious Anemia Virus Capsid Protein Extends Its Helix α1 at Capsid Assembly Locus
- Open Access
- 12 June 2012
- Published by Wiley in Molecular Biology International
- Vol. 2012, 1-12
HIV Assembly and Budding: Ca2+ Signaling and Non-ESCRT Proteins Set the Stage
More than a decade has elapsed since the link between the endosomal sorting complex required for transport (ESCRT) machinery and HIV-1 protein trafficking and budding was first identified. L domains in HIV-1 Gag mediate recruitment of ESCRT which function in bud abscission releasing the viral particle from the host cell. Beyond virus budding, the ESCRT machinery is also involved in the endocytic pathway, cytokinesis, and autophagy. In the past few years, the number of non-ESCRT host proteins shown to be required in the assembly process has also grown. In this paper, we highlight the role of recently identified cellular factors that link ESCRT machinery to calcium signaling machinery and we suggest that this liaison contributes to setting the stage for productive ESCRT recruitment and mediation of abscission. Parallel paradigms for non-ESCRT roles in virus budding and cytokinesis will be discussed.
- 12 June 2012
- Published by Wiley in Molecular Biology International
- Vol. 2012, 1-12
Open AccessHIV Assembly and Budding: Ca2+ Signaling and Non-ESCRT Proteins Set the Stage
More than a decade has elapsed since the link between the endosomal sorting complex required for transport (ESCRT) machinery and HIV-1 protein trafficking and budding was first identified. L domains in HIV-1 Gag mediate recruitment of ESCRT which function in bud abscission releasing the viral particle from the host cell. Beyond virus budding, the ESCRT machinery is also involved in the endocytic pathway, cytokinesis, and autophagy. In the past few years, the number of non-ESCRT host proteins shown to be required in the assembly process has also grown. In this paper, we highlight the role of recently identified cellular factors that link ESCRT machinery to calcium signaling machinery and we suggest that this liaison contributes to setting the stage for productive ESCRT recruitment and mediation of abscission. Parallel paradigms for non-ESCRT roles in virus budding and cytokinesis will be discussed.
- 22 August 2011
- Published by Elsevier in Journal of Molecular Biology
- Vol. 413 (2) , 347-358
ESCRT Machinery Potentiates HIV-1 Utilization of the PI(4,5)P2-PLC-IP3R-Ca2+ Signaling Cascade
- 22 August 2011
- Published by Elsevier in Journal of Molecular Biology
- Vol. 413 (2) , 347-358
ESCRT Machinery Potentiates HIV-1 Utilization of the PI(4,5)P2-PLC-IP3R-Ca2+ Signaling Cascade
- 22 July 2011
- Published by Elsevier in Journal of Molecular Biology
- Vol. 410 (4) , 716-725
Sprouty2 Regulates PI(4,5)P2/Ca2+ Signaling and HIV-1 Gag Release
- 22 July 2011
- Published by Elsevier in Journal of Molecular Biology
- Vol. 410 (4) , 716-725
Sprouty2 Regulates PI(4,5)P2/Ca2+ Signaling and HIV-1 Gag Release
- 15 July 2011
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (14) , 7353-7362
Sprouty 2 Binds ESCRT-II Factor Eap20 and Facilitates HIV-1 Gag Release
The four ESCRT ( e ndocytic s orting c omplexes r equired for t ransport) complexes (ESCRT-0, -I, -II, and -III) normally operate sequentially in the trafficking of cellular cargo. HIV-1 Gag trafficking and release as virus-like particles (VLPs) require the participation of ESCRTs; however, its use of ESCRTs is selective and nonsequential. Specifically, Gag trafficking to release sites on the plasma membrane does not require ESCRT-0 or -II. It is known that a bypass of ESCRT-0 is achieved by the direct linkage of the ESCRT-I component, Tsg101, to the primary L domain motif (PTAP) in Gag and that bypass of ESCRT-II is achieved by the linkage of Gag to ESCRT-III through the adaptor protein Alix. However, the mechanism by which Gag suppresses the interaction of bound ESCRT-I with ESCRT-II is unknown. Here we show (i) that VLP release requires the steady-state level of Sprouty 2 (Spry2) in COS-1 cells, (ii) that Spry2 binds the ESCRT-II component Eap20, (iii) that binding Eap20 permits Spry2 to disrupt ESCRT-I interaction with ESCRT-II, and (iv) that coexpression of Gag with a Spry2 fragment that binds Eap20 increases VLP release. Spry2 also facilitated release of P7L-Gag (i.e., release in the absence of Tsg101 binding). In this case, rescue required the secondary L domain (YPX n L) in HIV-1 Gag that binds Alix and the region in Spry2 that binds Eap20. The results identify Spry2 as a novel cellular factor that facilitates release driven by the primary and secondary HIV-1 Gag L domains.
- 15 July 2011
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (14) , 7353-7362
Sprouty 2 Binds ESCRT-II Factor Eap20 and Facilitates HIV-1 Gag Release
The four ESCRT ( e ndocytic s orting c omplexes r equired for t ransport) complexes (ESCRT-0, -I, -II, and -III) normally operate sequentially in the trafficking of cellular cargo. HIV-1 Gag trafficking and release as virus-like particles (VLPs) require the participation of ESCRTs; however, its use of ESCRTs is selective and nonsequential. Specifically, Gag trafficking to release sites on the plasma membrane does not require ESCRT-0 or -II. It is known that a bypass of ESCRT-0 is achieved by the direct linkage of the ESCRT-I component, Tsg101, to the primary L domain motif (PTAP) in Gag and that bypass of ESCRT-II is achieved by the linkage of Gag to ESCRT-III through the adaptor protein Alix. However, the mechanism by which Gag suppresses the interaction of bound ESCRT-I with ESCRT-II is unknown. Here we show (i) that VLP release requires the steady-state level of Sprouty 2 (Spry2) in COS-1 cells, (ii) that Spry2 binds the ESCRT-II component Eap20, (iii) that binding Eap20 permits Spry2 to disrupt ESCRT-I interaction with ESCRT-II, and (iv) that coexpression of Gag with a Spry2 fragment that binds Eap20 increases VLP release. Spry2 also facilitated release of P7L-Gag (i.e., release in the absence of Tsg101 binding). In this case, rescue required the secondary L domain (YPX n L) in HIV-1 Gag that binds Alix and the region in Spry2 that binds Eap20. The results identify Spry2 as a novel cellular factor that facilitates release driven by the primary and secondary HIV-1 Gag L domains.
- Open Access
Un-“ESCRT”-ed Budding
In their recent publication, Rossman et al. [1] describe how the inherent budding capability of its M2 protein allows influenza A virus to bypass recruitment of the cellular ESCRT machinery enlisted by several other enveloped RNA and DNA viruses, including HIV, Ebola, rabies, herpes simplex type 1 and hepatitis B. Studies from the same laboratory [2] and other laboratories [3–6] indicate that budding of plasmid-derived virus-like particles can be mediated by the influenza virus hemagglutinin and neuraminidase proteins in the absence of M2. These events are also independent of canonical ESCRT components [2,7]. Understanding how intrinsic properties of these influenza virus proteins permit ESCRT-independent budding expands our understanding of the budding process itself.
Open AccessUn-“ESCRT”-ed Budding
In their recent publication, Rossman et al. [1] describe how the inherent budding capability of its M2 protein allows influenza A virus to bypass recruitment of the cellular ESCRT machinery enlisted by several other enveloped RNA and DNA viruses, including HIV, Ebola, rabies, herpes simplex type 1 and hepatitis B. Studies from the same laboratory [2] and other laboratories [3–6] indicate that budding of plasmid-derived virus-like particles can be mediated by the influenza virus hemagglutinin and neuraminidase proteins in the absence of M2. These events are also independent of canonical ESCRT components [2,7]. Understanding how intrinsic properties of these influenza virus proteins permit ESCRT-independent budding expands our understanding of the budding process itself.
- Open Access
Phosphoinositides Direct Equine Infectious Anemia Virus Gag Trafficking and Release
Phosphatidylinositol 4,5‐biphosphate [PI(4,5)P2], the predominant phosphoinositide (PI) on the plasma membrane, binds the matrix (MA) protein of human immunodeficiency virus type 1 (HIV‐1) and equine infectious anemia virus (EIAV) with similar affinities in vitro. Interaction with PI(4,5)P2 is critical for HIV‐1 assembly on the plasma membrane. EIAV has been shown to localize in internal compartments; hence, the significance of its interaction with PI(4,5)P2 is unclear. We therefore investigated the binding in vitro of other PIs to EIAV MA and whether intracellular association with compartments bearing these PIs was important for assembly and release of virus‐like particles (VLPs) formed by Gag. In vitro, EIAV MA bound phosphatidylinositol 3‐phosphate [PI(3)P] with higher affinity than PI(4,5)P2 as revealed by nuclear magnetic resonance (NMR) spectra upon lipid titration. Gag was detected on the plasma membrane and in compartments enriched in phosphatidylinositol 3,5‐biphosphate [PI(3,5)P2]. Treatment of cells with YM201636, a kinase inhibitor that blocks production of PI(3,5)P2 from PI(3)P, caused Gag to colocalize with aberrant compartments and inhibited VLP release. In contrast to HIV‐1, release of EIAV VLPs was not significantly diminished by coexpression with 5‐phosphatase IV, an enzyme that specifically depletes PI(4,5)P2 from the plasma membrane. However, coexpression with synaptojanin 2, a phosphatase with broader specificity, diminished VLP production. PI‐binding pocket mutations caused striking budding defects, as revealed by electron microscopy. One of the mutations also modified Gag–Gag interaction, as suggested by altered bimolecular fluorescence complementation. We conclude that PI‐mediated targeting to peripheral and internal membranes is a critical factor in EIAV assembly and release.
Open AccessPhosphoinositides Direct Equine Infectious Anemia Virus Gag Trafficking and Release
Phosphatidylinositol 4,5‐biphosphate [PI(4,5)P2], the predominant phosphoinositide (PI) on the plasma membrane, binds the matrix (MA) protein of human immunodeficiency virus type 1 (HIV‐1) and equine infectious anemia virus (EIAV) with similar affinities in vitro. Interaction with PI(4,5)P2 is critical for HIV‐1 assembly on the plasma membrane. EIAV has been shown to localize in internal compartments; hence, the significance of its interaction with PI(4,5)P2 is unclear. We therefore investigated the binding in vitro of other PIs to EIAV MA and whether intracellular association with compartments bearing these PIs was important for assembly and release of virus‐like particles (VLPs) formed by Gag. In vitro, EIAV MA bound phosphatidylinositol 3‐phosphate [PI(3)P] with higher affinity than PI(4,5)P2 as revealed by nuclear magnetic resonance (NMR) spectra upon lipid titration. Gag was detected on the plasma membrane and in compartments enriched in phosphatidylinositol 3,5‐biphosphate [PI(3,5)P2]. Treatment of cells with YM201636, a kinase inhibitor that blocks production of PI(3,5)P2 from PI(3)P, caused Gag to colocalize with aberrant compartments and inhibited VLP release. In contrast to HIV‐1, release of EIAV VLPs was not significantly diminished by coexpression with 5‐phosphatase IV, an enzyme that specifically depletes PI(4,5)P2 from the plasma membrane. However, coexpression with synaptojanin 2, a phosphatase with broader specificity, diminished VLP production. PI‐binding pocket mutations caused striking budding defects, as revealed by electron microscopy. One of the mutations also modified Gag–Gag interaction, as suggested by altered bimolecular fluorescence complementation. We conclude that PI‐mediated targeting to peripheral and internal membranes is a critical factor in EIAV assembly and release.
- 1 July 2010
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (13) , 6438-6451
Activation of the Inositol (1,4,5)-Triphosphate Calcium Gate Receptor Is Required for HIV-1 Gag Release
The structural precursor polyprotein, Gag, encoded by all retroviruses, including the human immunodeficiency virus type 1 (HIV-1), is necessary and sufficient for the assembly and release of particles that morphologically resemble immature virus particles. Previous studies have shown that the addition of Ca 2+ to cells expressing Gag enhances virus particle production. However, no specific cellular factor has been implicated as mediator of Ca 2+ provision. The inositol (1,4,5)-triphosphate receptor (IP3R) gates intracellular Ca 2+ stores. Following activation by binding of its ligand, IP3, it releases Ca 2+ from the stores. We demonstrate here that IP3R function is required for efficient release of HIV-1 virus particles. Depletion of IP3R by small interfering RNA, sequestration of its activating ligand by expression of a mutated fragment of IP3R that binds IP3 with very high affinity, or blocking formation of the ligand by inhibiting phospholipase C-mediated hydrolysis of the precursor, phosphatidylinositol-4,5-biphosphate, inhibited Gag particle release. These disruptions, as well as interference with ligand-receptor interaction using antibody targeted to the ligand-binding site on IP3R, blocked plasma membrane accumulation of Gag. These findings identify IP3R as a new determinant in HIV-1 trafficking during Gag assembly and introduce IP3R-regulated Ca 2+ signaling as a potential novel cofactor in viral particle release.
- 1 July 2010
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (13) , 6438-6451
Activation of the Inositol (1,4,5)-Triphosphate Calcium Gate Receptor Is Required for HIV-1 Gag Release
The structural precursor polyprotein, Gag, encoded by all retroviruses, including the human immunodeficiency virus type 1 (HIV-1), is necessary and sufficient for the assembly and release of particles that morphologically resemble immature virus particles. Previous studies have shown that the addition of Ca 2+ to cells expressing Gag enhances virus particle production. However, no specific cellular factor has been implicated as mediator of Ca 2+ provision. The inositol (1,4,5)-triphosphate receptor (IP3R) gates intracellular Ca 2+ stores. Following activation by binding of its ligand, IP3, it releases Ca 2+ from the stores. We demonstrate here that IP3R function is required for efficient release of HIV-1 virus particles. Depletion of IP3R by small interfering RNA, sequestration of its activating ligand by expression of a mutated fragment of IP3R that binds IP3 with very high affinity, or blocking formation of the ligand by inhibiting phospholipase C-mediated hydrolysis of the precursor, phosphatidylinositol-4,5-biphosphate, inhibited Gag particle release. These disruptions, as well as interference with ligand-receptor interaction using antibody targeted to the ligand-binding site on IP3R, blocked plasma membrane accumulation of Gag. These findings identify IP3R as a new determinant in HIV-1 trafficking during Gag assembly and introduce IP3R-regulated Ca 2+ signaling as a potential novel cofactor in viral particle release.
- 1 October 2008
- Published by Annual Reviews in Annual Review of Microbiology
- Vol. 62 (1) , 425-443
Cell Biology of HIV-1 Infection of Macrophages
HIV infection of macrophages is a critically important component of viral pathogenesis and progression to AIDS. Although the virus follows the same life cycle in macrophages and T lymphocytes, several aspects of the virus-host relationship are unique to macrophage infection. Examples of these are the long-term persistence of productive infection, sustained by the absence of cell death, and the ability of progeny virus to bud into and accumulate in endocytic compartments designated multivesicular bodies (MVBs). Recently, the hypothesis that viral exploitation of the macrophage endocytic machinery is responsible for perpetuating the chronic state of infection unique to this cell type has been challenged in several independent studies employing a variety of experimental strategies. This review examines the evidence supporting and refuting the canonical hypothesis and highlights recently identified cellular factors that may contribute to the unique aspects of the HIV-macrophage interaction.
- 1 October 2008
- Published by Annual Reviews in Annual Review of Microbiology
- Vol. 62 (1) , 425-443
Cell Biology of HIV-1 Infection of Macrophages
HIV infection of macrophages is a critically important component of viral pathogenesis and progression to AIDS. Although the virus follows the same life cycle in macrophages and T lymphocytes, several aspects of the virus-host relationship are unique to macrophage infection. Examples of these are the long-term persistence of productive infection, sustained by the absence of cell death, and the ability of progeny virus to bud into and accumulate in endocytic compartments designated multivesicular bodies (MVBs). Recently, the hypothesis that viral exploitation of the macrophage endocytic machinery is responsible for perpetuating the chronic state of infection unique to this cell type has been challenged in several independent studies employing a variety of experimental strategies. This review examines the evidence supporting and refuting the canonical hypothesis and highlights recently identified cellular factors that may contribute to the unique aspects of the HIV-macrophage interaction.